Press release |


ADVANT Beiten Advises Dusseldorf-Based MedTech Company CUREosity Again on Financing Round

Dusseldorf, 2 July 2024 – The international commercial law firm ADVANT Beiten has advised CUREosity GmbH, Dusseldorf, on a growth financing round which brought the medtech company a total of approximately EUR 3.8 million from existing and new investors.

In addition to other investors and business angels, the existing investor Tech-Vision Fonds (TVF) and the Belgian family office Nomainvest were involved as new co-investors. The venture capital fund TVF, based in Aachen, specialises in companies in the medical technology sector, among others, and has been providing CUREosity with significant support since 2021. ADVANT Beiten already provided CUREosity with comprehensive advice during the financing round at that time.

Caesar van Heyningen, Thomas Saur and Stefan Arand head the Scale Up, founded in 2019, which develops innovative therapy software using virtual reality (VR) goggles. The VR therapy system was launched in February 2021. CE-certified as a medical device, the CUREO software combines years of therapy experience with neuroscientific findings, gamification, and smart technologies. CUREO supports cognitive and motor (especially upper limb) rehabilitation and is thus suitable for patients with neurological or motor impairments. In addition to multisensory training units, the software also offers therapy exercises for hand rehabilitation, attention training and neuroregulation. In varied, playful VR environments, patients' motivation, and willingness to engage in therapy are encouraged. The distraction created by VR also helps to reduce pain.

Since the market launch of CUREO, the software-as-a-service company has grown rapidly and is now being used in almost 200 therapeutic facilities. The newly acquired capital will be used, among other things, to further expand CUREO's market leadership in the field of VR therapy.
The completed financing round gives the innovative company financial independence and enables it to operate sustainably - especially in the current challenging market conditions.

Advisor to CUREosity GmbH: 
ADVANT Beiten: Dr Sebastian Weller, Markus Schönherr, Sarah Heinrichs, Simon Litterst (all Corporate/M&A/Venture Capital, Dusseldorf).
    
Advisor to TVF:
Forvis Mazars: Dr Philipp Wüllrich (Lead partner) and Yannik Metz (both Corporate/M&A/Venture Capital, Cologne), Florian Helbig (IP/IT/Data Protection, Leipzig).
    
Public Relations
Frauke Reuther
Manager Kommunikation
ADVANT Beiten
+49 (69) 75 60 95 - 570
frauke.reuther@advant-beiten.com

Dr Sebastian Weller
Lawyer
ADVANT Beiten
+49 (211) 51 89 89 - 134
sebastian.weller@advant-beiten.com
 


DOWNLOADS

ADVANT Beiten Advises Dusseldorf-Based MedTech Company CUREosity Again on Financing Round.pdf

pdf

DOWNLOAD